Drugs / umbilical cord blood mononuclear cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01673932 | Oct 2012 → Dec 2018 | brain ischemia, ischemic stroke | China Spinal Cord Injury Network | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | umbilical cord blood mononuclear cells | “umbilical cord blood mononuclear cells (UCBMC) treatment of chronic ischemic stroke.” NCT01673932 ↗ |
| Known as | UCBMC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01673932 ↗ |
| Modality | Cell therapy | “transplant of UCBMC isolated from HLA-matched umbilical cord blood” NCT01673932 ↗ |
| Route | Other | “into brain adjacent to the infracted site” NCT01673932 ↗ |